164 related articles for article (PubMed ID: 37024512)
1. High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy.
El Kebbi O; Prather CS; Elmuti L; Khalifeh M; Alali M
Sci Rep; 2023 Apr; 13(1):5627. PubMed ID: 37024512
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
3. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
4. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
6. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
7. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
8. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
9. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
Whittle SB; Williamson KC; Russell HV
Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
[TBL] [Abstract][Full Text] [Related]
13. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
14. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
[TBL] [Abstract][Full Text] [Related]
15. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
16. Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study.
Van Weelderen RE; Klein K; Goemans BF; Tissing WJE; Wolfs TFW; Kaspers GJL
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804942
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Su TY; Lee MH; Huang CT; Liu TP; Lu JJ
Medicine (Baltimore); 2018 Dec; 97(50):e13607. PubMed ID: 30558035
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
19. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]